News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER Research Update: September 2026
RECOVER researchers continue to publish findings that could help scientists, doctors, patients, and caregivers navigate the complexities of Long COVID.
Research Update
182 Results
182 Results
RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID
RECOVER researchers conducted a clinical trial to test whether PAXLOVID, an antiviral drug, could reduce Long COVID symptoms when taken for 15 or 25 days. The study enrolled 959 adults with Long COVID at 69 sites across the US.
News Release
RECOVER to launch next phase of pediatric observational study
In early 2027, RECOVER will launch the next phase of its pediatric study, following more than 4,300 children, teens, and young adults over 2 years to learn how Long COVID changes as they grow up.
Feature
Biosamples from RECOVER clinical trials offer expanded opportunities for Long COVID research
Biosamples collected during RECOVER clinical trials can provide valuable information about how people’s bodies respond to treatment. Researchers who receive funding through a new research opportunity can now access these samples.
Feature
RECOVER Representatives create resources for people living with Long COVID
Drawing on lived experience, RECOVER Representatives created 4 new resources to help people with Long COVID track symptoms, navigate work, find mental health support, and access financial assistance.
Feature
RECOVER launches new funding opportunity for pathobiology research
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
Announcement
RECOVER’s electronic health record study revealed early answers about COVID and Long COVID
RECOVER’s electronic health record study, which completed analyses in May, examined the health data of over 60 million people to advance Long COVID research.
Feature
New curriculum empowers future healthcare providers to recognize and treat Long COVID
A free online curriculum called LEARN prepares future healthcare providers to care for people with Long COVID. Built by doctors and students at 2 RECOVER study sites, LEARN bridges a gap some medical trainees see in their training.
Feature
R3 Seminar Recap: RECOVER clinical trial results and the pursuit of Long COVID treatments
During the July 14 RECOVER Research Review (R3) Seminar, panelists Craig Reist, PhD; David S. Knopman, MD; and Pam R. Taub, MD, shared findings from the RECOVER Clinical Trials (RECOVER-CT) program, the initiative's first wave of clinical trials. The trials focused on Long COVID symptoms related to thinking and memory, as well as the autonomic nervous system, which controls body functions like heart rate and blood pressure. RECOVER-CT Engagement Lead, Renee Leverty, MA, BSN, and Patient Representative Marta Cerda, JD, also explained how patient, caregiver, and community input shaped the trial design process.
R3 Seminar Recap